- Home
- PFD vs RENB Comparison
PFD vs RENB Comparison
Compare PFD & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFD
- RENB
- Stock Information
- Founded
- PFD 1990
- RENB 2011
- Country
- PFD United States
- RENB United States
- Employees
- PFD N/A
- RENB N/A
- Industry
- PFD Investment Managers
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- PFD Finance
- RENB Health Care
- Exchange
- PFD Nasdaq
- RENB Nasdaq
- Market Cap
- PFD 144.5M
- RENB 121.3M
- IPO Year
- PFD N/A
- RENB N/A
- Fundamental
- Price
- PFD $10.74
- RENB $0.35
- Analyst Decision
- PFD
- RENB
- Analyst Count
- PFD 0
- RENB 0
- Target Price
- PFD N/A
- RENB N/A
- AVG Volume (30 Days)
- PFD 33.2K
- RENB 855.6K
- Earning Date
- PFD 01-01-0001
- RENB 05-14-2025
- Dividend Yield
- PFD 6.30%
- RENB N/A
- EPS Growth
- PFD N/A
- RENB N/A
- EPS
- PFD N/A
- RENB N/A
- Revenue
- PFD N/A
- RENB N/A
- Revenue This Year
- PFD N/A
- RENB N/A
- Revenue Next Year
- PFD N/A
- RENB N/A
- P/E Ratio
- PFD N/A
- RENB N/A
- Revenue Growth
- PFD N/A
- RENB N/A
- 52 Week Low
- PFD $8.53
- RENB $0.32
- 52 Week High
- PFD $11.18
- RENB $2.70
- Technical
- Relative Strength Index (RSI)
- PFD 43.75
- RENB 29.29
- Support Level
- PFD $10.42
- RENB $0.35
- Resistance Level
- PFD $10.96
- RENB $0.39
- Average True Range (ATR)
- PFD 0.28
- RENB 0.07
- MACD
- PFD -0.01
- RENB -0.00
- Stochastic Oscillator
- PFD 46.85
- RENB 11.00
About PFD Flaherty & Crumrine Preferred and Income Fund Incorporated
Flaherty & Crumrine Prefd Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities, which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.